期刊名称：ANNALS OF THE RHEUMATIC DISEASES ISSN： 0003-4967 版本： SCI-CDE 出版频率： Monthly 出版社： BMJ PUBLISHING GROUP, BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND, WC1H 9JR   出版社网址： http://www.bmj.com/ 期刊网址： http://ard.bmj.com/ 影响因子： 19.103 主题范畴： RHEUMATOLOGY 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. Instructions to Authors Editorial policy Annals of the Rheumatic Diseases seeks to publish significant scientific advances which are likely to impact on clinical practice within the medium term. Articles illustrating basic mechanisms and their application to clinical material will be welcomed. We aim to cover all areas of Rheumatology and the journal has two main sections for original research articles - one for clinical and epidemiological research and one for basic and translational research. The priorities are originality and excellence. We aim to ensure a fair and independent peer review system and to publish articles which follow the highest ethical standards concerning research conduct. Open access/Unlocked articles Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,700(+VAT)/€2,515(+VAT)/$3,145. Article types and word counts Editorials View Points Review articles Recommendations and criteria articles Original research articles - Extended reports Original research articles - Concise reports Letters to the editor Matters arising (eLetter correspondence) Supplements The word count excludes the title page, abstract, tables, acknowledgements and contributions and the references. Supplementary material (eg additional tables, figures and text files (eg details from the methodology)) can be published online only. Editorials The aim of an Editorial is to stimulate thought (often with more questions than answers) rather than review the subject exhaustively. Editorials are usually linked to one or more articles published in the same issue. Personal opinion and comment are perfectly legitimate since the Editorial is not anonymous, though of course such opinion needs to be reasonable and backed up by appropriate evidence. Word count: up to 1200-1500 words. Illustrations/Tables: Maximum 2 tables and/or figures. References: up to 30. Viewpoints The aim of a viewpoint article is to communicate personal opinions and interpretation of available scientific data within a certain area. The viewpoint article can for example provide an interpretation of data that is relevant for clinical practice or clinical decision making or present a research agenda within a specific area based on available evidence. Word count: up to 1200-1500 words Illustrations/Tables: Maximum 2 tables and/or figures References: up to 30. Review Articles Although these are usually commissioned, authors are invited to discuss directly with the Editor possible topics for review. Word count: the length will be indicated by or will be discussed with the editor, but will usually be less than 3000 words. Abstract: up to 250 words. Tables/Illustrations: Maximum 6 tables and/or figures References: to be discussed with the Editor. Recommendations and criteria articles Recommendations for management of rheumatic diseases or new disease criteria are published in a separate section of the journal. Word count: the length will be indicated by or will be discussed with the editor, but will usually be less than 3000 words. Abstract: up to 250 words. Tables/illustrations: Maximum 6 tables and/or figures. References: to be discussed with the Editor. Original research articles - Extended reports These represent a substantial body of laboratory or clinical work. Extended reports should not exceed 3000 words plus references; articles that exceed this word limit may be returned for revision before peer review. Additional data may be presented as supplementary information, which will be published online only should the article be accepted (this can be in any format: text, tables, images, videos, etc.). Extended reports should be presented in sections - namely: Abstract No more than 250 words, summarising the problem being considered, how the study was performed, the salient results and the principal conclusions under subheadings 'Objectives', 'Methods', 'Results', and 'Conclusions'. Key words No more than 5. These should be given beneath the Abstract and in the box provided in the online submission process. Introduction Brief description of the background that led to the study (current results and conclusions should not be included). Methods Details relevant to the conduct of the study. Wherever possible give numbers of subjects studied (not percentages alone). Statistical methods should be clearly explained at the end of this section. Results Work should be reported in SI units. Undue repetition in text and tables should be avoided. Comment on validity and significance of results is appropriate but broader discussion of their implication is restricted to the next section. Subheadings that aid clarity of presentation within this and the previous section are encouraged. Discussion The nature and findings of the study are placed in context of other relevant published data. Caveats to the study should be discussed. Avoid undue extrapolation from the study topic. Acknowledgments and affiliations Individuals with direct involvement in the study but not included in authorship may be acknowledged. The source of financial support and industry affiliations of all those involved must be stated. References (no limit � but usually below 50). Please see References for further style guidance. Figure legends Maximum 6 tables and/or figures. Please see Illustrations and tables for further style guidance. Original research articles - Concise reports The format is identical to that of an Extended Report (see above) and should include an Abstract, Keywords, Introduction, Methods, Results and Discussion (for cases, 'Case Reports' will substitute for Methods and Results). Word count: up to 1500 words. Abstract: up to 200 words. Tables/illustrations: Maximum 3 tables and/or figures. References: up to 20. Letters to the editor Short clinical or laboratory observations may be presented as a Letter to the Editor. Letters are not divided into sections, while instructions for references, tables, and figures are the same as for full length articles. Case reports may be published as a letter if the case is of exceptional importance and interest. Word count: up to 500 words. Abstract: not required. Tables/Illustrations: Maximum 2 tables and/or figures. References: Maximum 10. Matters arising (eLetter correspondence) Letters in response to articles published in ARD are welcome and should be submitted electronically via the website. Contributors should go to the abstract or full text of the article in question. At the top right corner of each article is a "contents box". Click on the "eLetters: Submit a response to this article" link. Letters relating to or responding to previously published items in the journal will be reviewed by the editor and shown to the authors of the original article, when appropriate.   Supplements The BMJ Publishing Group journals are willing to consider publishing supplements to regular issues. Supplement proposals may be made at the request of: The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement. The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought. The BMJPG itself may have proposals for supplements where sponsorship may be necessary. A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement. In all cases, it is vital that the journal's integrity, independence and academic reputation is not compromised in any way. Annals of Rheumatic Diseases are currently publishing supplements from the EULAR congress and the European Workshop for Rheumatological Research (EWRR). Editorial Board Editor Tore K Kvien Competing interests >> Diakonhjemmet Hospital Oslo, Norway t.k.kvien@medisin.uio.no Associate Editors Francis Berenbaum Hôpital Saint Antoine, Paris, France francis.berenbaum@sat.aphp.fr Johannes Bijlsma UMC Utrecht Utrecht, The Netherlands j.w.j.bijlsma@umcutrecht.nl Dimitrios Boumpas University of Crete Heraklion, Greece boumpasd@med.uoc.gr Gerd Burmester Charité University Hospital Berlin, Germany gerd.burmester@charite.de Mary Crow Hospital for Special Surgery New York, USA crowm@hss.edu Iain McInnes University Glasgow Glasgow, UK i.b.mcinnes@clinmed.gla.ac.uk Methodological Advisor Stian Lydersen NTNU Trondheim, Norway Editorial Board Daniel Aletaha Medical University of Vienna Vienna, Austria Maarten Boers VU University Medical Centre Amsterdam, The Netherlands Loreto Carmona Fundación Española de Reumatología Madrid, Spain Bernard Combe CHU Lapeyronie Montpellier, France Philip Conaghan University of Leeds Leeds, UK Andrew Cope Imperial College London London, UK Maurizio Cutolo University of Genova Genova, Italy Laszlo Czirjak University of Pecs Pecs, Hungary Thomas Dörner Charite University Hospital Berlin, Germany Gary Firestein UCSD School of Medicine San Diego, USA David Fox University of Michigan Ann Arbor, USA Sherine Gabriel Mayo Clinic Rochester, USA Piet Geusens University Hospital Maastricht Maastricht, The Netherlands Juan J Gómez-Reino Hospital Clinico Universitario Santiago, Spain Walter Grassi University of Ancona Jesi, Italy Wolfgang Gross Medical University of Lubeck Lubeck, Germany Francis Guillemin University Henry Poincare Nancy, France Kåre Birger Hagen Diakonhjemmet Hospital Oslo, Norway Frederic Houssiau Cliniques Universitaires Saint-Luc Brussels, Belgium Tom Huizinga LUMC, Leiden, The Netherlands Roland Jonsson University of Bergen Bergen, Norway Christian Jorgensen Hôpital Lapeyronie Montpellier, France George Kollias Biomedical Sciences Research Centre Athens, Greece Robert Landewé University Hospital Maastricht Maastricht, The Netherlands Ingrid Lundberg Karolinska Institutet Stockholm, Sweden Frank Luyten University Hospital KU Leuven Leuven, Belgium Xavier Mariette Hôpital de Bicêtre Bicêtre, France Wlodzimierz Maslinski Institute of Rheumatology Warsaw, Poland Marco Mattuci Cerinic University of Florence Florence, Italy Pierre Miossec University of Lyon Lyon, France Kusuki Nishioka Institute of Medical Science Kanagawa, Japan Mike Nurmohamed VU University Medical Centre Amsterdam, The Netherlands Monika Østensen University Hospital Bern, Switzerland Mikkel Østergaard Hvidovre University Hospital Hvidovre, Denmark Seza Özen Hacettepe University Medical Faculty Ankara, Turkey Leonardo Punzi University of Padova Padova, Italy Lars Rönnblom Uppsala University Hospital Uppsala, Sweden Georg Schett University of Vienna Vienna, Austria José da Silva Hospitais da Universidade Coimbra Coimbra, Portugal Hendrik Schulze-Koops University of München München, Germany Alexander So Service de RMR Lausanne, Switzerland Tuulikki Sokka Jyvaskyla Central Hospital Jyvaskyla, Finland Deborah Symmons University of Manchester Manchester, UK Paul-Peter Tak AMC Amsterdam Amsterdam, The Netherlands Alan Tyndall Felix Platter Spital Basel, Switzerland Jiri Vencovsky Institute of Rheumatology Prague, Czech Republic Ronald van Vollenhoven Karolinska University Hospital Stockholm, Sweden Michael Ward National Institute of Health Bethesda, USA